| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00377104 NCT01645579 Details | 2013-07-02 Interventional | 1 | 24 | Alvocidib Leukemia Leukemia, Lymph… Leukemia, Lymph… Lymphoma B-cell Chronic … Contiguous Stag… Noncontiguous S… Stage I Chronic… Stage I Small L… Stage II Chroni… Stage III Chron… Stage III Small… Stage IV Chroni… Stage IV Small … | - - | |||
| NCT00098618 Details | 2013-07-02 Interventional | 2 | 40 | Interferon alph… Interferon-alph… Interferons Sorafenib Carcinoma Carcinoma, Rena… Clear Cell Rena… Papillary Renal… Recurrent Renal… Stage III Renal… Stage IV Renal … | - - | |||
| NCT00098527 Details | 2013-07-02 Interventional | 2 | 20 | Romidepsin Adenocarcinoma Esophageal Neop… Recurrence Adenocarcinoma … Adenocarcinoma … Recurrent Esoph… Recurrent Gastr… | - - | |||
| NCT00079443 Details | 2013-07-01 Interventional | 2 | 60 | Fludarabine Fludarabine pho… Rituximab Romidepsin Leukemia, Lymph… Lymphoma Lymphoma, Folli… Recurrence Recurrent Grade… Recurrent Grade… Recurrent Small… | - - | |||
| NCT00334867 Details | 2013-06-28 Interventional | 3 | 0 | Cyclophosphamid… Dexrazoxane Doxorubicin Etoposide Ifosfamide Liposomal doxor… Razoxane Topotecan Vincristine Sarcoma Sarcoma, Ewing | withdrawn - | |||
| NCT00834899 Details | 2013-06-27 Interventional | 1/2 | 13 | Eptifibatide Anemia, Sickle … Sickle Cell Dis… | Slow accrual and no cost extension not approved by NHLBI The study was terminated early resulting in small numbers of subjects analyzed. | |||
| NCT01600807 Details | 2013-06-26 Interventional | 1/2 | 0 | Erlotinib Hydro… Gemcitabine Adenocarcinoma Pancreatic Canc… | Study was pending major changes and was on hold, pending activation; administratively
withdrawn; will be submitted as a new protocol if study is revised. - | |||
| NCT01017822 Details | 2013-06-24 Interventional | 1/2 | 0 | Capecitabine Conatumumab Gemcitabine Pancreatic Neop… Pancreatic Canc… | This study was withdrawn due to study agent availability. - | |||
| NCT00773383 2008-001762-85 Details | 2013-06-24 Interventional | 2 | 35 | Erlotinib Hydro… Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | - - | |||
| NCT01617213 Details | 2013-06-21 Interventional | 2 | 1 | Lenalidomide Melphalan Multiple Myelom… Neoplasms, Plas… | Study is no longer needed as recent data have answered the primary hypotheses for this study. - | |||
| NCT01881997 Details | 2013-06-20 Interventional | 4 | [10 Refs] | 0 | Fentanyl Abscess | IRB modifications made study impractical. - | ||
| NCT01402596 Details | 2013-06-20 Interventional | 2 | 0 | Chloral Hydrate Midazolam Brain Injuries Brain Injuries,… Computed Tomogr… Procedural Seda… Traumatic Brain… | Institution decided on starting a new protocol of sedation, with another methods and that´s why
this study has not started. - | |||
| NCT01834183 Details | 2013-06-19 Interventional | 2 | 0 | Gemcitabine Tivozanib Carcinoma Carcinoma, Rena… Renal Cell Carc… | Sponsor Aveo has withdrawn support for this trial. - | |||
| NCT01115036 Details | 2013-06-19 Interventional | 2 | 0 | Panobinostat Glioblastoma Recurrence Recurrent Gliob… | No subjects were enrolled on this study, so study was closed and IND withdrawn. - | |||
| NCT00589238 Details | 2013-06-19 Interventional | 2 | 16 | Carboplatin Cyclophosphamid… Doxorubicin Liposomal doxor… Paclitaxel Breast Neoplasm… Breast Cancer | - - | |||
| NCT00281255 Details | 2013-06-19 Interventional | 1/2 | 0 | Allopurinol Dobutamine Cardiomyopathie… Cardiomyopathy,… Cardiovascular … Heart Diseases Heart Failure Heart Failure, … | Infeasible - | |||
| NCT01880112 Details | 2013-06-18 Interventional | 4 | 0 | Cefazolin Infections Antibiotic Prop… Cesarean Delive… Infection | There is no longer need for this study. - | |||
| NCT00908024 2009-013766-78 Details | 2013-06-18 Interventional | 1/2 | 54 | Cetuximab Neoplasm Metast… Colorectal Canc… Head and Neck C… | - - | |||
| NCT01405950 Details | 2013-06-17 Interventional | 1 | 10 | Clonidine Tizanidine Cerebral Palsy Muscle Spastici… Spasticity Due … | Please see 'Further study details as provided by Acorda Therapeutics' for explanation of why
study stopped. - | |||
| NCT01017237 Details | 2013-06-17 Interventional | 4 | 18 | Dexmedetomidine Ketamine Midazolam Anesthesia | Protocol proved to be ineffective for adequate sedation for third molar surgery. Early termination due to ineffective sedation. We had to abandon the protocol in 5 of 10 patients in the dexmedetomidine plus midazolam group and 2 of 8 patients in the dexmedetomidine plus midazolam and ketamine group because of combative behavior. |